Feature Channels: AIDS and HIV

Filters close
Released: 7-Apr-2020 9:50 AM EDT
Depressive Disorders Are ‘Under Recognized and Under Treated’ in People with HIV/AIDS
Wolters Kluwer Health: Lippincott Williams and Wilkins

People living with HIV/AIDS are at increased risk of depressive disorders. But all too often, these conditions go unrecognized or untreated, suggests a literature review in the May/June issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Released: 11-Mar-2020 10:30 AM EDT
Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai
Mount Sinai Health System

Appointment Enhances Efforts by the Institute to Improve Health of Communities Locally and Internationally

Newswise: Curcumin is the spice of life when delivered via tiny nanoparticles
Released: 5-Mar-2020 8:05 AM EST
Curcumin is the spice of life when delivered via tiny nanoparticles
University of South Australia

For years, curry lovers have sworn by the anti-inflammatory properties of turmeric, but its active compound, curcumin, has long frustrated scientists hoping to validate these claims with clinical studies.

3-Mar-2020 3:50 PM EST
Shedding light on hidden HIV
Universite de Montreal

Initiating antiretroviral therapy at a very early stage makes HIV reservoirs shrink by 100 times, researchers in Canada, the U.S. and Thailand find.

Released: 26-Feb-2020 10:05 AM EST
Patients Better Informed About Health After HIV And HCV Tests That Give Immediate Results
Johns Hopkins University Carey Business School

When substance use disorder patients were tested for both HIV and hepatitis C virus at the same time and given the results within 20 minutes, they were far more likely a month later to indicate they had received results, compared with patients who were referred for testing services.

Newswise: Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
Released: 26-Feb-2020 9:00 AM EST
Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
Texas Biomedical Research Institute

More than $3.7 million was awarded to Mahesh Mohan, DVM, MS, Ph.D., Professor at the Texas Biomedical Research Institute, and Chioma M. Okeoma, Ph.D., Associate Professor at Stony Brook University, to explore the link between cannabinoids (THC) and chronic intestinal inflammation in patients infected with the human immunodeficiency virus (HIV).

Newswise: New clues emerge on how to block reemergence of HIV
Released: 12-Feb-2020 2:45 PM EST
New clues emerge on how to block reemergence of HIV
University of Washington School of Medicine

“We wanted to answer the question ‘How does HIV bounce back when treatment is stopped?'" said Dr. Florian Hladik.

Newswise: José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health
Released: 10-Feb-2020 11:10 AM EST
José A. Bauermeister, PhD, Appointed Chair of Penn Nursing’s Department of Family and Community Health
University of Pennsylvania School of Nursing

José A. Bauermeister, PhD, MPH, Presidential Professor of Nursing, will be the next Chair of the University of Pennsylvania School of Nursing’s (Penn Nursing) Department of Family and Community Health, effective July 1, 2020.

Released: 10-Feb-2020 9:00 AM EST
Study Finds Innate Protein that Restricts HIV Replication by Targeting Lipid Rafts
George Washington University

A recent study from the George Washington University suggests that the innate protein AIBP restricts HIV-1 replications by targeting the lipid rafts the virus relies on.

Released: 6-Feb-2020 5:05 AM EST
Study Uses Powerful Sequencing Technology to Study HIV Epidemic in Washington, DC
George Washington University

Despite significant progress against HIV/AIDS, the nation’s capital is still battling an HIV epidemic with rates that are five times higher than the national average. A study published today in the journal Scientific Reports uses powerful next-generation sequencing technology to learn more about how the virus is spreading and developing drug resistance in the District of Columbia.


Showing results

110 of 10

close
0.52595